| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.77▼ | 3.77▼ | 3.78▼ | 3.92▼ | 3.90▼ |
| MA10 | 3.79▼ | 3.78▼ | 3.78▼ | 3.97▼ | 3.86▼ |
| MA20 | 3.79▼ | 3.79▼ | 3.85▼ | 3.96▼ | 3.86▼ |
| MA50 | 3.79▼ | 3.91▼ | 3.98▼ | 3.86▼ | 5.38▼ |
| MA100 | 3.79▼ | 4.00▼ | 3.97▼ | 4.10▼ | 6.68▼ |
| MA200 | 3.85▼ | 3.98▼ | 3.95▼ | 4.91▼ | 7.30▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | 0.004▲ | -0.004▼ | -0.031▼ | 0.095▲ |
| RSI | 27.077▼ | 35.214▼ | 34.581▼ | 41.789▼ | 41.839▼ |
| STOCH | 4.167▼ | 36.520 | 25.976 | 34.837 | 60.975 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -96.154▼ | -54.645 |
| CCI | -302.197▼ | -141.026▼ | -93.333 | -169.858▼ | 17.071 |
|
Friday, October 10, 2025 11:01 AM
Fintel reports that on October 10, 2025, HC Wainwright & Co. reiterated coverage of Altimmune (NasdaqGM:ALT) with a Buy recommendation. As of September 30, 2025, the average one-year price target for ...
|
|
Thursday, September 25, 2025 07:21 AM
PHILADELPHIA, Sept. 25, 2025 /PRNewswire/ -- Berger Montague PC is investigating claims under the federal securities laws against Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company"), a ...
|
|
Tuesday, August 05, 2025 04:31 AM
GAITHERSBURG, Md., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2025 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/11/25 | 3.75 | 3.83 | 3.73 | 3.75 | 2,587,925 |
| 04/11/25 | 3.89 | 3.98 | 3.74 | 3.76 | 3,143,690 |
| 03/11/25 | 4.03 | 4.05 | 3.925 | 3.96 | 2,169,568 |
| 31/10/25 | 4.25 | 4.25 | 3.99 | 4.05 | 2,430,762 |
| 30/10/25 | 4.05 | 4.25 | 4.02 | 4.07 | 3,995,768 |
| 29/10/25 | 4.06 | 4.07 | 3.93 | 4.00 | 2,300,119 |
| 28/10/25 | 4.15 | 4.15 | 4.0411 | 4.06 | 1,736,426 |
| 27/10/25 | 3.99 | 4.145 | 3.99 | 4.14 | 2,911,134 |
| 24/10/25 | 4.00 | 4.10 | 3.94 | 3.95 | 1,913,148 |
| 23/10/25 | 3.92 | 4.04 | 3.90 | 3.96 | 1,923,494 |
|
|
||||
|
|
||||
|
|